Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitestemgent.com
Twitter@Stemgent
CategoryBioTech
Phone617-245-0000
Employees
Founded2008
Descriptionstem cell research

Offices

Cambridge, USA
One Kendall Square, B6201
Cambridge, MA, 02139
USA

People

Chief Financial Officer
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Chief Commercial Officer
Executive Chairman

Funding

TOTAL $47.9M
FUNDING TOTAL $47.9M
Series B, 3/2009
Frazier Healthcare Ventures
Morgenthaler Ventures
$14M
Partial Close, 5/2010
$5.63M
Series B, 6/2011
HealthCare Ventures
Morgenthaler Ventures
$10.6M
Venture Round, 2/2012
$6.3M
Venture Round, 8/2012
$11.3M
DEBT TOTAL $4.03M
Debt, 11/2009
HealthCare Ventures
Morgenthaler Ventures
$2.7M
Debt, 4/2011
$750k
Debt, 10/2011
$580k

Tags

Stemgent

Stemgent works alongside some of the world’s leading stem cell scientists in developing innovative technology and application solutions that provide researchers the tools to investigate and understand cellular reprogramming. Our mission is to help simplify and support stem cell research by producing products and services being designed by leading stem cell researchers. Specialties Cellular Reprogramming, iPS Cells, Media, Human iPSC Training & Services, mRNA Reprogramming, Stem Cell Research, Custom iPS cell lines, Pluriton, WIT, StainAlive, NutriStem

Recent Milestones

Videos

Screenshots

Stemgent screenshot
Above: Home Page
Uploaded: 11/26/09

Sources

  1. Stemgent Nails Down $14M to Make Supplies, Tools for Stem Cell Researchers (xconomy.com) [edit]
  2. Stemgent issues notes to raise $2.7M (masshightech.com) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. SEC (sec.gov) [edit]
  6. Stemgent grabs $580K in debt funding (masshightech.com) [edit]
  7. Stemgent adds $6.3M to coffers to grow portfolio (masshightech.com) [edit]
  8. Stemgent rakes in $11M, largest round to date (masshightech.com) [edit]
  9. Stemgent to buy Asterand’s human tissue biz for $9M (masshightech.com) [edit]
Edit This Page
Last Edited 12/15/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy